🩺 ANTI-GOUT PREPARATIONS 🏷️ Xanthine oxidase inhibitor
👨‍⚕️ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
📅 Reviewed: November 2026 • 🔍 Authority: DRAP / WHO ATC
📦 Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Tab 40 mg 103251 10 Rs.355 Rs.418
Tab 80 mg 103252 10 Rs.656 Rs.772

📋 Indications & Clinical Dosage

*Treatment of chronic hyperuricaemia in gout:* Adult: Initially 80 mg once daily, if after 2-4 weeks of initial dose, serum uric acid greater than 6 mg/100ml then increase dose; increased if necessary to 120 mg once daily. *Prophylaxis and treatment of acute hyperuricaemia with initial chemotherapy for haematologic malignancies:* Adult: 120 mg once daily, to be started 2 days before start of cytotoxic therapy and continued for 7-9 days, according to chemotherapy duration.

⛔ Contraindications

Not a treatment for acute gout but continue if attack develops when already receiving allopurinol, and treat attack separately

⚠️ Precautions & Warnings

Congestive heart failure, ischaemic heart disease, thyroid disorders, transplant recipients, elderly, renal or hepatic impairment, ensure adequate fluid intake (2-3 litres/day), for hyperuricaemia associated with cancer therapy, allopurinol treatment should be started before cancer therapy. Administer prophylactic NSAID (not aspirin or salicylates) or colchicine until at least 1 month after hyperuricaemia corrected (for first 3 months) to avoid precipitating an acute attack. Perform LFTs, before and periodically during treatment.

🔄 Drug Interactions

Mercaptopurine, azathioprine, theophylline, glucuronidation inducers.

⚠️ Adverse Reactions / Side Effects

Abnormal liver function tests, GI disturbances, headache, oedema, rash, renal failure, appetite change, arthralgia, arthritis, atrial fibrillation, bronchitis, bursitis, chest pain, cholelithiasis, dermatitis, diabetes mellitus, dizziness, drowsiness, dyspnea, ECG abnormalities, erectile dysfunction, flushing, haematuria, hemiparesis, hyperlipidaemia, hypertension, hypoaesthesia, increased thyroid stimulating hormone, increased urinary frequency, insomnia, muscle spasm, muscle weakness, myalgia, nephrolithiasis, palpitation, paraesthesia, proteinuria, taste disturbances, weight change

🤰 Pregnancy & Lactation Safety

Pregnancy Risk:
Contraindicated in pregnancy.
Lactation / Breastfeeding:
Contraindicated

📚 Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: FEBUXOSTAT

ADENURIC
SOLACE PHARMA
Rs.560.00
Rs.781.13
BARISTAT
BARRETT HODGSON
Rs.500.00
BUXO
GENIX
Rs.540.00
DEURIC
GENETICS
Rs.476.00 560.00
DYXOSTAT
DYSON R L
Rs.501.5 590.00

More from SEARLE

ACOEAZE
SEARLE
Rs.800.00
ACTINIB
SEARLE
Rs.8500.00
Rs.826

Same category: ANTI-GOUT PREPARATIONS

AGOUT
MEGA
Rs.112.99
BENIPRO
SHROOQ
Rs.110.50
Rs.309.17

⚡ Quick Actions

💬 Share via WhatsApp